IP Library Granted Patent US 10,201,550
Granted Patent B2
US 10,201,550 · App. 15/742,425 · Granted Feb 12, 2019

Oxysterols and methods of use thereof

Inventors: Francesco G. Salituro (Marlborough, MA); Albert Jean Robichaud (Cambridge, MA); Gabriel Martinez Botella (Wayland, MA)
Assignee: Sage Therapeutics, Inc.
A61K31/575C07J9/00C07J7/002C07J9/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,201,550
App. No.
15/742,425
Granted
Feb 12, 2019
Kind
B2
Abstract

Compounds are provided according to Formula (I): Formula (I) and pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof; wherein R 1 , R 2 , R 3 , R 6 , R 7 , R 8 , and n are as defined herein. Compounds of the present invention are contemplated useful for the prevention and treatment of a variety of conditions.

Claims (3)

1. A compound of the formula:

2. A pharmaceutical composition comprising a compound of the formula:

and a pharmaceutically acceptable excipient.

Assignments (3)
CHANGE OF NAME Recorded Mar 17, 2026
From: SAGE THERAPEUTICS, INC.
To: SAGE THERAPEUTICS, LLC
Reel/Frame 075171/0142 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2025
From: SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT JEAN; BOTELLA, GABRIEL MARTINEZ
To: SAGE THERAPEUTICS, INC.
Reel/Frame 071341/0279 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 6, 2025
From: SALITURO, FRANCESCO G.; ROBICHAUD, ALBERT JEAN; BOTELLA, GABRIEL MARTINEZ
To: SAGE THERAPEUTICS, INC.
Reel/Frame 071341/0875 →
Continuity (3)
Provisional Application 62189048 · Jul 6, 2015
Provisional Application 62280394 · Jan 19, 2016
Related Publication 20180200267A1 · Jul 19, 2018
Cited By (5)
US 12,268,697 US 12,331,070 US 12,448,409 US 12,540,157 US 12,617,814